We are live on ! Find out more
NPF

Norris Perne & French Portfolio holdings

AUM $1.71B
1-Year Est. Return 30.87%
This Fund
S&P 500
This Quarter Est. Return
-5.9%
1 Year Est. Return
+30.87%
3 Year Est. Return
+78.29%
5 Year Est. Return
+102.93%
10 Year Est. Return
+464.45%
AUM
$962M
AUM Growth
-$78.5M
Cap. Flow
+$312K
Cap. Flow %
0.03%
Top 10 Hldgs %
29.83%
Holding
139
New
5
Increased
64
Reduced
24
Closed
9

Top Buys

Rank Stock Value
1
HUBS icon
HubSpot
HUBS
+$13.5M
2
KLAC icon
KLA
KLAC
+$7.96M
3
MSFT icon
Microsoft
MSFT
+$5.11M
4
ZBRA icon
Zebra Technologies
ZBRA
+$3.67M
5
DIS icon
Walt Disney
DIS
+$3.01M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.3M
2
MIDD icon
Middleby
MIDD
+$12.5M
3
CGNX icon
Cognex
CGNX
+$6.53M
4
MRK icon
Merck
MRK
+$6.29M
5
OGN icon
Organon & Co
OGN
+$2.42M

Sector Composition

Rank Sector Weight
1 Technology 28.47%
2 Industrials 14.26%
3 Healthcare 12.68%
4 Consumer Discretionary 9.71%
5 Financials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLKN icon
126
MillerKnoll
MLKN
$1.63B
$201K 0.02%
12,880
KMI icon
127
Kinder Morgan
KMI
$69.2B
$172K 0.02%
10,366
NEA icon
128
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.41B
$129K 0.01%
12,130
OPK icon
129
Opko Health
OPK
$1.02B
$125K 0.01%
66,000
ALTO icon
130
Alto Ingredients
ALTO
$339M
$40K ﹤0.01%
10,900
CGNX icon
131
Cognex
CGNX
$10.8B
-153,600
Closed -$6.53M
CNI icon
132
Canadian National Railway
CNI
$75.9B
-1,800
Closed -$202K
ED icon
133
Consolidated Edison
ED
$39.2B
-2,330
Closed -$222K
GLD icon
134
SPDR Gold Trust
GLD
$142B
-1,197
Closed -$202K
IP icon
135
International Paper
IP
$21.8B
-6,300
Closed -$264K
MIDD icon
136
Middleby
MIDD
$5.96B
-99,768
Closed -$12.5M
PFE icon
137
Pfizer
PFE
$153B
-4,756
Closed -$249K
PGR icon
138
Progressive
PGR
$125B
-2,025
Closed -$235K
TYL icon
139
Tyler Technologies
TYL
$12.9B
-1,508
Closed -$502K

Similar funds

Norris Perne & French's Q3 2022 Portfolio in Review

As of Q3 2022, Norris Perne & French held 139 positions worth $962M, down 7.5% from $1.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Norris Perne & French's Q3 2022 filing shows 5 new, 64 increased, 24 reduced and 9 closed positions. Its largest new stake was HubSpot: 42,447 shares worth $11.5M. The largest sale was Bristol-Myers Squibb, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Norris Perne & French's largest Q3 2022 buy was HubSpot: 42,447 shares worth $11.5M.
  • Norris Perne & French added most to Microsoft in Q3 2022, an estimated $5.11M increase.
  • Norris Perne & French's biggest Q3 2022 reduction was Bristol-Myers Squibb, cutting an estimated $19.3M.
  • Norris Perne & French fully exited Middleby in Q3 2022, selling an estimated $12.5M.
  • Norris Perne & French's ten largest holdings make up 30% of its $962M portfolio in Q3 2022.
  • Norris Perne & French opened 5 new positions and closed 9 in Q3 2022.
  • Norris Perne & French's portfolio value fell 7.5% quarter-over-quarter to $962M.

Based on Norris Perne & French's 13F filing for Q3 2022, filed 13 Oct 2022.